ÂÜÀòÂÒÂ×

Christopher Rovaldi has served as their Chief Operating Officer since February 2022. Prior to joining Keros, Mr. Rovaldi served as a consultant to biotechnology companies. Previously, Mr. Rovaldi held multiple positions of increasing responsibility at Acceleron Pharma Inc., including his most recent role as Senior Vice President, Program Management and Operations. He also previously worked at Idenix Pharmaceuticals, Inc. and at Cubist Pharmaceuticals, Inc. He has over 20 years of program and portfolio management experience developing biologics and small molecules from the pre-investigational new drug application stage to marketing authorization.

Mr. Rovaldi received a B.S. and an M.Sc. degree each in Microbiology from the University of New Hampshire.